Advertisement.

IMMPF Projected Dividend Yield

Immupharma PLC ( OTCBB : IMMPF )

Immupharma is a drug discovery and development company engaged in research, development and commercialization of novel drugs, largely based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. Co.'s drug candidates include: Lupuzor™, used as treatment for lupus, which is a chronic, autoimmune, inflammatory disease; BioGlucagon, a therapy for low sugar events in diabetes; BioAMP-B, a peptide-based drug for potential improvement on Amphotericin-B, one of the treatments used for serious and life threatening fungal infections such as aspergillosis (lung infection); and Nucant cancer platform (IPP-204106) for treatment in cancer and ophthalmology.

20 YEAR PERFORMANCE RESULTS

IMMPF Dividend History Detail
IMMPF Dividend News
IMMPF Competitors News

# of Shares: 0

Closing Price: 0.09

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000